🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Status
Completed
Location
AZ Sint-Jan
Start Date
2003-11
Trial ID
NCT00077116
RATIONALE: Vorinostat may stop the growth of cancer cells by interfering wi...
Status
Terminated
Location
Stanford University
Start Date
2008-03
Trial ID
NCT00673153
Treatments Being Tested
MRD driven study. Addition of gemtuzumab to conventional chemotherapy to re...
Status
Recruiting
Location
A.O. - SS. Antonio e Biagio e Cesare Arrigo - SC Ematologia
Start Date
2020-09-24
Trial ID
NCT04168502
Treatments Being Tested
This phase II trial is studying the side effects of giving azacitidine toge...
Status
Active Not Recruiting
Location
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Start Date
2008-12-01
Trial ID
NCT00658814
Treatments Being Tested
This is a prospective, single-center phase 1 clinical study aimed at determ...
Status
Completed
Location
Froedtert Hospital & the Medical College of Wisconsin
Start Date
2019-05-24
Trial ID
NCT03848754
The purpose of this study is to find out how safe and effective the combina...
Status
Completed
Location
Weill Medcial College of Cornell University
Start Date
2003-05
Trial ID
NCT00195000
Treatments Being Tested
This study will test an experimental combination of the drugs Mylotarg and ...
Status
Completed
Location
UCSD Moores Cancer Center
Start Date
2005-07
Trial ID
NCT00766116
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of talazoparib...
Status
Completed
Location
University of Maryland Greenebaum Cancer Center
Start Date
2020-10-23
Trial ID
NCT04207190
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
UAB Comprehensive Cancer Center
Start Date
2006-08
Trial ID
NCT00372593
Randomized Phase-III, two-arm, open-label, multi-center study in adult pati...
Status
Completed
Location
Medizinische Universitäts Graz
Start Date
2010-05-12
Trial ID
NCT00893399
Treatments Being Tested